Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2012
Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study
B Kasenda, E Schorb, K Fritsch, et al.
British Journal of Cancer
|
January 23, 2016
Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma
S Diem, B Kasenda, L Spain, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 10, 2011
Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly
K Fritsch, B Kasenda, C Hader, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 3, 2015
Planning and reporting of quality-of-life outcomes in cancer trials
S Schandelmaier, K Conen, E von Elm, et al.
ESMO Open
|
January 8, 2022
Targeting immunoliposomes to EGFR-positive glioblastoma
B Kasenda, D König, M Manni, et al.
ESMO Real World Data and Digital Oncology
|
April 3, 2026
Final results of the INFINITY precision oncology registry: non-standard targeted treatments in patients with advanced cancers in routine care
L Sellmann, D Marschner, U M Martens, et al.
Leukemia
|
June 1, 2017
High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group
B Kasenda, G Ihorst, R Schroers, et al.
Bone Marrow Transplantation
|
April 25, 2017
High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study
E Schorb, C P Fox, K Fritsch, et al.
Immuno-Oncology Technology
|
January 13, 2025
Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanoma
D König, B Kasenda, M Sandholzer, et al.
Leukemia
|
November 16, 2016
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)
K Fritsch, B Kasenda, E Schorb, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2012
Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study
B Kasenda, E Schorb, K Fritsch, et al.
British Journal of Cancer
|
January 23, 2016
Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma
S Diem, B Kasenda, L Spain, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 10, 2011
Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly
K Fritsch, B Kasenda, C Hader, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 3, 2015
Planning and reporting of quality-of-life outcomes in cancer trials
S Schandelmaier, K Conen, E von Elm, et al.
ESMO Open
|
January 8, 2022
Targeting immunoliposomes to EGFR-positive glioblastoma
B Kasenda, D König, M Manni, et al.
ESMO Real World Data and Digital Oncology
|
April 3, 2026
Final results of the INFINITY precision oncology registry: non-standard targeted treatments in patients with advanced cancers in routine care
L Sellmann, D Marschner, U M Martens, et al.
Leukemia
|
June 1, 2017
High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group
B Kasenda, G Ihorst, R Schroers, et al.
Bone Marrow Transplantation
|
April 25, 2017
High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study
E Schorb, C P Fox, K Fritsch, et al.
Immuno-Oncology Technology
|
January 13, 2025
Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanoma
D König, B Kasenda, M Sandholzer, et al.
Leukemia
|
November 16, 2016
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)
K Fritsch, B Kasenda, E Schorb, et al.
Page
of 2